Institutional investors purchased a net $6.4 million shares of OPK during the quarter ended September 2014. This may signal that the smart money is gaining interest in this company as the 17.81% of the shares outstanding that institutional investors hold is among the lowest in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
FIDELITY MANAGEMENT & RESEARCH C... Bought 1.1 Million shares of OPKO Health Inc
GROUP ONE TRADING LP Bought 660.4 Thousand shares of OPKO Health Inc
SUSQUEHANNA FINANCIAL GROUP LLLP Bought 651.4 Thousand shares of OPKO Health Inc